Brian Bateman

Stanford University School of Medicine, United States

Disclosure information not submitted.

Presentation(s):

• SC-17 - Pregnancy Pharmacoepidemiology: Evidence Generation and Interpretation for Decision- Making

  Saturday, August 23, 2025
  9:00 AM - 12:30 PM ET

• 1C-04 - The Comparative Effectiveness and Safety of Labetalol Versus Nifedipine for the Treatment of Chronic Hypertension During Pregnancy

  Sunday, August 24, 2025
  11:15 AM - 11:30 AM ET

• 1E-02 - Risk of Opioid Overdose Associated with Concurrent Use of Hydrocodone and CYP3A4-inhibiting Calcium Channel Blockers

  Sunday, August 24, 2025
  10:45 AM - 11:00 AM ET

• 1E-03 - Opioid Overdose Associated With Concomitant Use of Hydrocodone And Selective Serotonin Reuptake Inhibitors

  Sunday, August 24, 2025
  11:00 AM - 11:15 AM ET

• 1F-03 - Validation of ICD-10 Diagnosis Codes for Antepartum Anemia

  Sunday, August 24, 2025
  11:00 AM - 11:15 AM ET

• 1F-06 - Optimization of ICD-10-based algorithms for estimating gestational age for live and non-live births in healthcare databases

  Sunday, August 24, 2025
  11:45 AM - 12:00 PM ET

• 2G-06 - Benzodiazepines and spontaneous abortions: sequential target trial emulation design and other methodological considerations

  Sunday, August 24, 2025
  4:45 PM - 5:00 PM ET

• 3B-04 - Utilization Patterns of Anticoagulants Before, During, and After Pregnancy in the United States

  Monday, August 25, 2025
  9:00 AM - 9:15 AM ET

• 3G-01 - GLP-1 receptor agonist continuation into the first trimester of pregnancy and risk of non-live birth and abnormal fetal growth: a target trial emulation

  Monday, August 25, 2025
  8:15 AM - 8:30 AM ET

• 4F-04 - Clinically Recognized Congenital Cytomegalovirus Infection and the Risk of Neurodevelopmental Disorders

  Monday, August 25, 2025
  5:00 PM - 5:15 PM ET